metformin has been researched along with insulin detemir in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 16 (88.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davies, MJ; Farmer, AJ; Holman, RR; Keenan, JF; Levy, JC; Paul, S; Thorne, KI | 1 |
| Almdal, T; Boesgaard, T; Breum, L; Dunn, E; Gade-Rasmussen, B; Gluud, C; Hedetoft, C; Jarloev, A; Jensen, T; Johansen, LB; Krarup, T; Lund, SS; Lundby Christensen, L; Madsbad, S; Mathiesen, E; Moelvig, J; Nielsen, F; Pedersen, O; Perrild, H; Roeder, M; Sneppen, SB; Snorgaard, O; Tarnow, L; Thorsteinsson, B; Vaag, A; Vestergaard, H; Wetterslev, J; Wiinberg, N | 1 |
| Christensen, TE; Gundgaard, J; Thomsen, TL | 1 |
| Hollander, P; Liutkus, JF; Raslova, K; Råstam, J; Skjøth, TV | 1 |
| Shanik, MH | 1 |
| Bain, SC; D'Alessio, D; DeVries, JH; Rodbard, HW; Rosenstock, J; Seufert, J; Thomsen, AB; Zychma, M | 1 |
| Adetunji, O; Davies, M; Heller, S; Sapin, H; Sreenan, S; Tahbaz, A; Vora, J | 1 |
| Demissie, M; Hollander, P; Kesavadev, J; Meneghini, L; Nazeri, A | 1 |
| Bramlage, P; Fleischmann, H; Hanefeld, M; Schiffhorst, G | 1 |
| Behera, BN; Bhansali, A; Gangadhar, P; Gupta, R; Palikhe, G; Sachdeva, N | 1 |
| Caputo, S; Damci, T; Khunti, K; Orozco-Beltran, D; Pan, C; Svendsen, AL; Sølje, KS; Vora, J | 1 |
| Andersen, TH; Choi, DS; Chow, F; Christiansen, JS; Gall, MA; Hirao, K; Kaneko, S; Park, Y; Taneda, S | 1 |
| Almdal, TP; Boesgaard, TW; Breum, L; Carstensen, B; Duun, E; Gade-Rasmussen, B; Gluud, C; Hedetoft, C; Hemmingsen, B; Jensen, T; Krarup, T; Lund, SS; Lundby-Christensen, L; Madsbad, S; Mathiesen, ER; Pedersen, O; Perrild, H; Røder, M; Sneppen, SB; Snorgaard, O; Tarnow, L; Thorsteinsson, B; Vaag, A; Vestergaard, H; Wetterslev, J; Wiinberg, N | 1 |
| Gupta, Y; Kalra, S | 1 |
| Almdal, TP; Cichosz, SL; Hejlesen, OK; Johansen, MD; Lundby-Christensen, L; Tarnow, L | 1 |
| Banu, I; Charnaux, N; Cosson, E; Fysekidis, M; Sutton, A; Takbou, K; Valensi, P; Vicaut, E | 1 |
| Barrientos-Perez, M; Liang, B; Lo, FS; Lunsford, A; Thórisdóttir, Ó; Wheeler, MD; Zuckerman-Levin, N | 1 |
| Considine, RV; Goodwill, AG; Green, MA; Hamilton, L; Hutchins, GD; Mather, KJ; Mathias, C; Patel, NA; Territo, W; Tune, JD | 1 |
1 review(s) available for metformin and insulin detemir
| Article | Year |
|---|---|
Intensifying insulin therapy with insulin analog premixes: transitioning from basal insulin in type 2 diabetes.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Aspart; Insulin Detemir; Insulin Lispro; Insulin, Long-Acting; Male; Metformin; Postprandial Period; Randomized Controlled Trials as Topic | 2012 |
13 trial(s) available for metformin and insulin detemir
| Article | Year |
|---|---|
Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes.
Topics: Administration, Oral; Aged; Blood Glucose; Data Interpretation, Statistical; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Aspart; Insulin Detemir; Insulin, Long-Acting; Metformin; Middle Aged; Probability; Sulfonylurea Compounds; Treatment Outcome; Weight Gain | 2007 |
Study rationale and design of the CIMT trial: the Copenhagen Insulin and Metformin Therapy trial.
Topics: Adult; Aged; Biphasic Insulins; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy, Combination; Epidemiologic Methods; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Aspart; Insulin Detemir; Insulin, Isophane; Insulin, Long-Acting; Male; Metformin; Middle Aged; Research Design; Treatment Outcome; Tunica Intima; Tunica Media; Young Adult | 2009 |
Efficacy and safety of insulin detemir once daily in combination with sitagliptin and metformin: the TRANSITION randomized controlled trial.
Topics: Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Detemir; Insulin, Long-Acting; Male; Metformin; Middle Aged; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles; Weight Loss | 2011 |
Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1C targets.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Detemir; Insulin, Long-Acting; Liraglutide; Male; Metformin; Middle Aged | 2012 |
Once-weekly exenatide versus once- or twice-daily insulin detemir: randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas.
Topics: Aged; Diabetes Mellitus, Type 2; Exenatide; Female; Humans; Hypoglycemic Agents; Insulin Detemir; Insulin, Long-Acting; Male; Metformin; Middle Aged; Peptides; Sulfonylurea Compounds; Treatment Outcome; Venoms | 2013 |
Once-daily initiation of basal insulin as add-on to metformin: a 26-week, randomized, treat-to-target trial comparing insulin detemir with insulin glargine in patients with type 2 diabetes.
Topics: Argentina; Blood Glucose; Body Mass Index; Body Weight; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy, Combination; Fasting; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin Detemir; Insulin Glargine; Insulin, Long-Acting; Male; Metformin; Middle Aged; Patient Satisfaction; Republic of Korea; Thailand; Treatment Outcome; United States | 2013 |
Effect of once-daily insulin detemir on oral antidiabetic drug (OAD) use in patients with type 2 diabetes.
Topics: Administration, Oral; Aged; Diabetes Mellitus, Type 2; Drug Administration Schedule; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin Detemir; Insulin, Long-Acting; Male; Metformin; Middle Aged; Prospective Studies; Sulfonylurea Compounds; Thiazolidinediones | 2014 |
Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: a 26-week, randomised, treat-to-target trial.
Topics: Adult; Aged; Asian People; Biphasic Insulins; Blood Glucose; Diabetes Mellitus, Type 2; Drug Combinations; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Aspart; Insulin Detemir; Insulin, Isophane; Insulin, Long-Acting; Male; Metformin; Middle Aged; Treatment Failure | 2015 |
Effects of biphasic, basal-bolus or basal insulin analogue treatments on carotid intima-media thickness in patients with type 2 diabetes mellitus: the randomised Copenhagen Insulin and Metformin Therapy (CIMT) trial.
Topics: Blood Glucose; Body Weight; Carotid Intima-Media Thickness; Denmark; Diabetes Mellitus, Type 2; Drug Administration Schedule; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Aspart; Insulin Detemir; Male; Metformin; Middle Aged; Treatment Outcome | 2016 |
Prediction of excessive weight gain in insulin treated patients with type 2 diabetes.
Topics: Aged; Biphasic Insulins; Blood Glucose; Chi-Square Distribution; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Aspart; Insulin Detemir; Logistic Models; Male; Metformin; Middle Aged; Prognosis; Time Factors; Treatment Outcome; Weight Gain | 2017 |
Effects of insulin analogs as an add-on to metformin on cutaneous microcirculation in type 2 diabetic patients.
Topics: Administration, Cutaneous; Adult; Aged; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; France; Humans; Hypoglycemic Agents; Insulin Aspart; Insulin Detemir; Iontophoresis; Male; Metformin; Microcirculation; Middle Aged; Pilot Projects; Regional Blood Flow; Skin; Time Factors; Treatment Outcome; Vasodilator Agents | 2018 |
A 26-week, randomized trial of insulin detemir versus NPH insulin in children and adolescents with type 2 diabetes (iDEAt2).
Topics: Adolescent; Blood Glucose; Child; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Detemir; Insulin, Isophane; Life Style; Male; Metformin | 2018 |
Combination GLP-1 and Insulin Treatment Fails to Alter Myocardial Fuel Selection vs. Insulin Alone in Type 2 Diabetes.
Topics: Adult; Blood Glucose; Coronary Circulation; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Heart; Humans; Hypoglycemic Agents; Insulin Detemir; Liraglutide; Male; Metformin; Middle Aged; Myocardium; Treatment Outcome | 2018 |
4 other study(ies) available for metformin and insulin detemir
| Article | Year |
|---|---|
Direct healthcare costs of patients with type 2 diabetes using long-acting insulin analogues or NPH insulin in a basal insulin-only regimen.
Topics: Adolescent; Adult; Ambulatory Care; Chi-Square Distribution; Child; Child, Preschool; Cost-Benefit Analysis; Denmark; Diabetes Mellitus, Type 2; Drug Costs; Female; General Practice; Health Care Costs; Humans; Hypoglycemic Agents; Infant; Infant, Newborn; Insulin; Insulin Detemir; Insulin Glargine; Insulin, Isophane; Insulin, Long-Acting; Logistic Models; Male; Metformin; Middle Aged; Models, Economic; Odds Ratio; Outcome and Process Assessment, Health Care; Pharmaceutical Services; Primary Health Care; Propensity Score; Referral and Consultation; Registries; Time Factors; Treatment Outcome; Young Adult | 2010 |
Predictors of response to early basal insulin treatment in patients with type 2 diabetes--the EARLY experience.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Detemir; Insulin Glargine; Insulin, Long-Acting; Male; Maximum Tolerated Dose; Metformin; Predictive Value of Tests; Prospective Studies; Treatment Outcome | 2014 |
Efficacy of laparoscopic sleeve gastrectomy and intensive medical management in obese patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Comorbidity; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Exenatide; Female; Gastrectomy; Humans; Hypertension; Hypoglycemic Agents; Insulin Detemir; Insulin, Long-Acting; Laparoscopy; Male; Metformin; Middle Aged; Peptides; Quality of Life; Treatment Outcome; Venoms; Young Adult | 2014 |
A patient centred approach to basal insulin choice for the management of type 2 diabetes mellitus.
Topics: Checklist; Clinical Decision-Making; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Insulin; Insulin Detemir; Insulin Glargine; Insulin, Isophane; Insulin, Long-Acting; Metformin; Patient-Centered Care | 2016 |